
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105446-105446
Closed Access | Times Cited: 20
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105446-105446
Closed Access | Times Cited: 20
Showing 20 citing articles:
Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors
Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107481-107481
Closed Access | Times Cited: 59
Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107481-107481
Closed Access | Times Cited: 59
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12033-12058
Closed Access | Times Cited: 30
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12033-12058
Closed Access | Times Cited: 30
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 16
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 16
Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer
Sravani Pulya, Tarun Patel, Milan Paul, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114470-114470
Closed Access | Times Cited: 28
Sravani Pulya, Tarun Patel, Milan Paul, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114470-114470
Closed Access | Times Cited: 28
Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer
Milan Paul, Balaram Ghosh, Swati Biswas
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128281-128281
Closed Access | Times Cited: 13
Milan Paul, Balaram Ghosh, Swati Biswas
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128281-128281
Closed Access | Times Cited: 13
Synthesis, cytotoxicity, Pan-HDAC inhibitory activity and docking study of new N-(2-aminophenyl)-2-methylquinoline-4-carboxamide and (E)-N-(2-aminophenyl)-2-styrylquinoline-4-carboxamide derivatives as anticancer agents
Negar Omidkhah, Farzin Hadizadeh, Afshin Zarghi, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 3, pp. 506-524
Closed Access | Times Cited: 11
Negar Omidkhah, Farzin Hadizadeh, Afshin Zarghi, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 3, pp. 506-524
Closed Access | Times Cited: 11
Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives
Mohammad Ibrahim, Mohamad Nurul Azmi, Maram B. Alhawarri, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
Mohammad Ibrahim, Mohamad Nurul Azmi, Maram B. Alhawarri, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects
Jinxiao Ru, Yuxi Wang, Zijia Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115800-115800
Closed Access | Times Cited: 10
Jinxiao Ru, Yuxi Wang, Zijia Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115800-115800
Closed Access | Times Cited: 10
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117636-117636
Closed Access
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117636-117636
Closed Access
Caspase‐driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications
Meghana Allani, Akhilesh Akhilesh, Vinod Tiwari
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 3
Meghana Allani, Akhilesh Akhilesh, Vinod Tiwari
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 3
Fragment-based structural exploration and chemico-biological interaction study of HDAC3 inhibitors through non-linear pattern recognition, chemical space, and binding mode of interaction analysis
Suvankar Banerjee, Shraddha Dumawat, Tarun Jha, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-23
Closed Access | Times Cited: 8
Suvankar Banerjee, Shraddha Dumawat, Tarun Jha, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-23
Closed Access | Times Cited: 8
HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
S. Rajaraman, Ranjani Balakrishnan, Dhruv Deshmukh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 885-908
Closed Access | Times Cited: 6
S. Rajaraman, Ranjani Balakrishnan, Dhruv Deshmukh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 885-908
Closed Access | Times Cited: 6
Synergistic Anticancer Response via Docetaxel- and Oleanolic Acid-Loaded Albumin/Poly(lactide) Nanoparticles in Triple-Negative Breast Cancer
Sneha Das, Milan Paul, Balaram Ghosh, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 21, pp. 19710-19726
Closed Access | Times Cited: 6
Sneha Das, Milan Paul, Balaram Ghosh, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 21, pp. 19710-19726
Closed Access | Times Cited: 6
Synthesis and biological activity evaluation of podophyllotoxin-linked bile acid derivatives as potential anti-liver cancer agents
Desheng Cai, Shao-Yan Lou, Su Huo, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106066-106066
Closed Access | Times Cited: 8
Desheng Cai, Shao-Yan Lou, Su Huo, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106066-106066
Closed Access | Times Cited: 8
Synthesis and docking studies of pyran, pyridine and thiophene derivatives and their antitumor evaluations against cancer, hepatocellular carcinoma and cervical carcinoma cell lines
Rafat M. Mohareb, Rehab A. Ibrahim, Eman M. Samir
Journal of the Iranian Chemical Society (2023) Vol. 20, Iss. 9, pp. 2163-2187
Closed Access | Times Cited: 4
Rafat M. Mohareb, Rehab A. Ibrahim, Eman M. Samir
Journal of the Iranian Chemical Society (2023) Vol. 20, Iss. 9, pp. 2163-2187
Closed Access | Times Cited: 4
Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases
Marta Chierichetti, Mauro Cerretani, A Ciammaichella, et al.
Life Sciences (2022) Vol. 322, pp. 121323-121323
Open Access | Times Cited: 5
Marta Chierichetti, Mauro Cerretani, A Ciammaichella, et al.
Life Sciences (2022) Vol. 322, pp. 121323-121323
Open Access | Times Cited: 5
Synthesis, Characterisation, Single Crystal Structure and Evaluation of a Redox Innocent Carbazate Functionalized Phenanthroline for Antimycobacterial and Anticancer Activity
Ravallika Aluri, Aishwarya Natarajan, Tarun Patel, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140729-140729
Closed Access
Ravallika Aluri, Aishwarya Natarajan, Tarun Patel, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140729-140729
Closed Access
Derivatives of D(−)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis
Sanjib Das, Tarun Patel, Ambati Himaja, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108057-108057
Closed Access
Sanjib Das, Tarun Patel, Ambati Himaja, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108057-108057
Closed Access
Anti-Breast Cancer Potential of New Indole Derivatives: Synthesis, In-Silico Study, and Cytotoxicity Evaluation on MCF-7 Cells
Rehab Ganay Abood, Heider A. Abdulhussein, Sabah Abbas, et al.
Journal of Molecular Structure (2024), pp. 141176-141176
Closed Access
Rehab Ganay Abood, Heider A. Abdulhussein, Sabah Abbas, et al.
Journal of Molecular Structure (2024), pp. 141176-141176
Closed Access
Synthesis and Biological Activity Evaluation of Podophyllotoxin- Linked Bile Acids Derivatives As Potential Anti-Liver Cancer Agents
Desheng Cai, Shaoyan Lou, Su Huo, et al.
SSRN Electronic Journal (2022)
Closed Access
Desheng Cai, Shaoyan Lou, Su Huo, et al.
SSRN Electronic Journal (2022)
Closed Access